Beam Therapeutics Inc. — Director's Dealing 2021

Jun 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Verve Therapeutics, Inc. (VERV)
CIK: 0001840574
Period of Report: 2021-06-21

Reporting Person: Beam Therapeutics Inc. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-21	Common Stock	C	270895	—	Acquired	546970	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-21	Series A Convertible Preferred Stock	$	C	2508361	Disposed		Common Stock (270895)	Direct

Footnotes

F1: The convertible preferred stock automatically converted into shares of the Issuer's common stock, par value $0.001 per share, on a 9.2595-for-1 basis immediately prior to the closing of the Issuer's initial public offering. The preferred stock had no expiration date.